Company: CSTL
Filing Date: 2025-03-28
Form Type: PRE 14A
Source: 0001447362-25-000050
Chunk: 47

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-03-28
Form: PRE 14A
Chunk 47
---
 performance-based. In 2024 and 2025, the performance-based equity awards represented 50% of the total equity award value for our CEO and approximately 25% of our other NEOs based on the grant date fair value reported in the Summary Compensation Table. We added two new three-year performance metrics to our 2024 awards that are separate from the metrics under our short-term incentive program and moved from a two-year performance period to a three-year performance period. In addition to revenue, successful launch of a new commercial test and achieving positive EBITDA was included as the two new performance metrics in our 2024 awards.

While the total compensation awarded to our NEOs during fiscal 2024 may appear to imply an increase in compensation, this change is due to the shift in our annual grant cycle from the fourth quarter of fiscal 2023 to the first quarter of the following year, resulting in no equity grants in 2023. This adjustment better aligns with our business priorities and reinforces our commitment to rewarding sustained performance and creating shareholder value, as detailed below.

### EXECUTIVE COMPENSATION PHILOSOPHY AND OBJECTIVES
We have designed our executive compensation program to attract, retain, and motivate our executive officers, including our NEOs, by offering competitive compensation packages consisting of a base salary, an annual cash bonus, and long-term equity incentive awards, at a level consistent with market trends and industry data that we believe allows us to compete for the best talent in the highly-competitive environment in which we operate.

We believe the approach that has been adopted by our Compensation Committee, which includes consistent stockholder outreach and consideration of the feedback we receive, with its emphasis on variable cash

#### Castle Biosciences 2025 Proxy Statement47

#### Compensation Discussion and Analysis
compensation, time-based equity awards, and performance-based equity awards, enables us to attract top talent, motivate successful short-term and long-term performance, satisfy our retention objectives, and align the compensation of our executive officers with our performance and long-term value creation for our stockholders.

### SUMMARY OF OUR EXECUTIVE COMPENSATION PROGRAM
Our compensation program is designed to compensate our executive officers fairly based upon an assessment of compensation available in the marketplace where we compete for executive personnel and our desire to achieve a balance of short-term and long-term rewards for maintaining and improving Company performance and stockholder value. It is administered by our Compensation Committee.

We believe our compensation program has assisted us in achieving strong performance for our customers, employees and stockholders. For